<DOC>
	<DOCNO>NCT02650050</DOCNO>
	<brief_summary>Diabetes major cause blindness adult develop country . The retinal damage associate diabetes lead gradual loss vision , accentuate macula affect . This result macular edema . Currently , intravitreal injection anti-VEGF demonstrate effectiveness first line treatment macular edema . Subthreshold micropulsed laser photocoagulation alternative conventional grid photocoagulation . By deliver pulsed impact thermal lesion threshold pigment epithelium , would cause side effect conventional photocoagulation . Micropulsed photocoagulation combine anti-VEGF injection , could effective treatment minimum injection number without epithelial lesion . The main objective study show subthreshold micropulsed laser photocoagulation , association intravitreal injection anti-VEGF , allow reduce number anti-VEGF injection first year treatment . In randomized , double blind study , eligible patient randomize micropulsed laser photocoagulation arm sham micropulsed laser photocoagulation arm .</brief_summary>
	<brief_title>Micropulsed Laser Association With Anti-VEGF Treatment Macular Edema Diabetic Patients ( LAMED ) .</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>18 year macular edema associate 1 type 2 diabetes hemoglobin A1C level 5.5 % &lt; 13 % indication treatment intravitreal injection ranibizumab treatment antiVEGF previous 2 month treatment intravitreous implant dexamethasone previous six month previous history vitrectomy glaucoma photocoagulation previous 3 month patient 's opposition participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>